[account_shop_links]
Benchmarking Investigator Payments
$4,900.00 – $9,800.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
It goes without saying that Sponsors and CROs can’t afford to get the investigator payment level wrong. The downsides of not paying market-rate investigator fees impact both the financial health of the organization and the ability to recruit high-performing and experienced sites. Pay too much and your budget evaporates, pay too little and it will be difficult to recruit experienced sites.
How you can use this report:
- Benchmark your investigator payments against industry averages to establish and negotiate contracts
- Understand how “trial complexity” and “length of study” impact investigators’ willingness to participate and the impact on investigator fees
- Institute more realistic feasibility assessments and site start-up timing by understanding which therapeutic areas, phases, and types of products carry the highest cost
Therapeutic Areas:
- Cardiovascular
- CNS
- Gastrointestinal
- Infectious Diseases
- Internal Medicine
- Metabolic Diseases
- Musculoskeletal/Arthritis
- Oncology
- Pediatric
- Respiratory/Allergy
- Women’s Health
Analysis By:
- Therapeutic area
- Phase of development (I, II, III, IV)
- Compound type (Biologic, Biosimilar, Me-too, Generic, Novel)
Report Contents:
- Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
- Service Provider Selection Drivers
- Service Provider Performance
- Study Data
